Specialty immunotherapy biotech developing off-the-shelf precision T cell therapeutics.
New Jersey
- Tweets 48
- Following 2
- Followers 14
- Likes 63
RT @Tevogen: 📰 globenewswire.com/news-relea…
Tevogen is a healthcare enterprise focused on improving the affordability and accessibility of life…
6
RT @TevogenBio: Tevogen Bio Announces 2026 Annual Meeting of Stockholders
📰 globenewswire.com/news-relea…
The Annual Meeting will be held virtu…
5
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
📰 globenewswire.com/news-relea…
The Annual Meeting will be held virtually. Stockholders of record as of July 23, 2026 will be entitled to receive notice of and vote at the Annual Meeting or any adjournment thereof.
$TVGN
6
8
528
RT @TevogenBio: 🇺🇸 Happy Fourth of July from Tevogen. Today, we celebrate independence, opportunity, and the shared pursuit of a healthier…
3
RT @TevogenBio: A little #TBT to a day we will never forget.
We are proud of how far we have come, and even more energized by where we are…
4
RT @DrRyanSaadi: The most powerful pharmacy in the world isn’t on a street corner. It’s already inside our veins. @TevogenBio - #Tcell
🌐 h…
5
RT @TevogenBio: 📰 globenewswire.com/news-relea…
“Tevogen’s evaluation of potential MSO and CRO acquisitions reflects a disciplined approach to b…
4
RT @TevogenBio: At JPM43 Mittul Mehta, @Head_TevogenAI and @drhew
Chief Medical Officer & VP of Healthcare at
@Microsoft discussed AI in Bi…
4
RT @TevogenBio: Dr. Neal Flomenberg, Chief Scientific Officer, and Lori Grosso, Clinical Lead, discussed @TevogenBio's goal of making cytot…
1
3
RT @TevogenBio: 📰 tevogen.com/press-release/te…
“Capital discipline and preserving the integrity of our capital structure are core priorities fo…
1
3
RT @TevogenBio: 📰 tevogen.com/press-release/te…
“We anticipate this opportunity together with previously announced CRO evaluation and other stra…
3
RT @TevogenBio: 📰 tevogen.com/press_release/le…
🔹Loss from operations declined 51%, from $53.6 million in 2024 to $26.1 million in 2025.
🔹Q1 20…
5
RT @TevogenBio: 📰 tevogen.com/press_release/te…
“Having The Patel Family, LLP continue to support Tevogen reflects a shared belief in both our m…
3
RT @TevogenBio: 📰 globenewswire.com/news-relea…
“Advancing PredicTcell toward completion marks an important milestone in our AI strategy,” said…
4
RT @TevogenBio: 🔗 databricks.com/blog/tevogen-…
As part of our ongoing work on PredicTcell™, we’ve been leveraging scalable data infrastructure…
4
RT @TevogenBio: 📰 globenewswire.com/news-relea…
With compliance restored, Tevogen continues to advance its evolution into a diversified, fully i…
1
RT @TevogenBio: 📰 globenewswire.com/news-relea…
@DrRyanSaadi, Founder and CEO of Tevogen stated, "Long COVID is a clinical emergency affecting h…
3
RT @TevogenBio: 📰 globenewswire.com/news-relea…
“The potential acquisition of a CRO could introduce revenue-generating service capabilities whil…
1
25
📰 globenewswire.com/news-relea…
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
$TVGN #Sciometrix #Clinicus #HealthcareTechnology #Revenue #Strategy @TevogenBio @TevogenAI
1
4
5
516
The potential transaction is being explored to augment Tevogen’s existing capabilities and would result in Tevogen becoming a revenue-generating healthcare enterprise.
$TVGN #Sciometrix #Clinicus #HealthcareTechnology #Revenue #Strategy
1
2
100